These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 27309570

  • 1. Fatty Acid Amide Hydrolase (FAAH), Acetylcholinesterase (AChE), and Butyrylcholinesterase (BuChE): Networked Targets for the Development of Carbamates as Potential Anti-Alzheimer's Disease Agents.
    Montanari S, Scalvini L, Bartolini M, Belluti F, Gobbi S, Andrisano V, Ligresti A, Di Marzo V, Rivara S, Mor M, Bisi A, Rampa A.
    J Med Chem; 2016 Jul 14; 59(13):6387-406. PubMed ID: 27309570
    [Abstract] [Full Text] [Related]

  • 2. Piperazine and piperidine carboxamides and carbamates as inhibitors of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL).
    Korhonen J, Kuusisto A, van Bruchem J, Patel JZ, Laitinen T, Navia-Paldanius D, Laitinen JT, Savinainen JR, Parkkari T, Nevalainen TJ.
    Bioorg Med Chem; 2014 Dec 01; 22(23):6694-6705. PubMed ID: 25282655
    [Abstract] [Full Text] [Related]

  • 3. A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase.
    Gattinoni S, Simone CD, Dallavalle S, Fezza F, Nannei R, Battista N, Minetti P, Quattrociocchi G, Caprioli A, Borsini F, Cabri W, Penco S, Merlini L, Maccarrone M.
    Bioorg Med Chem Lett; 2010 Aug 01; 20(15):4406-11. PubMed ID: 20591666
    [Abstract] [Full Text] [Related]

  • 4. Synthesis, structural characterization, docking, lipophilicity and cytotoxicity of 1-[(1R)-1-(6-fluoro-1,3-benzothiazol-2-yl)ethyl]-3-alkyl carbamates, novel acetylcholinesterase and butyrylcholinesterase pseudo-irreversible inhibitors.
    Pejchal V, Štěpánková Š, Pejchalová M, Královec K, Havelek R, Růžičková Z, Ajani H, Lo R, Lepšík M.
    Bioorg Med Chem; 2016 Apr 01; 24(7):1560-72. PubMed ID: 26947959
    [Abstract] [Full Text] [Related]

  • 5. Design and synthesis of new carbamates as inhibitors for fatty acid amide hydrolase and cholinesterases: Molecular dynamic, in vitro and in vivo studies.
    Maleki MF, Nadri H, Kianfar M, Edraki N, Eisvand F, Ghodsi R, Mohajeri SA, Hadizadeh F.
    Bioorg Chem; 2021 Apr 01; 109():104684. PubMed ID: 33607363
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A novel series of tacrine-selegiline hybrids with cholinesterase and monoamine oxidase inhibition activities for the treatment of Alzheimer's disease.
    Lu C, Zhou Q, Yan J, Du Z, Huang L, Li X.
    Eur J Med Chem; 2013 Apr 01; 62():745-53. PubMed ID: 23454517
    [Abstract] [Full Text] [Related]

  • 8. Exploration of dual fatty acid amide hydrolase and cholinesterase inhibitory potential of some 3-hydroxy-3-phenacyloxindole analogs.
    Tripathi RKP, Ayyannan SR.
    Arch Pharm (Weinheim); 2020 Sep 01; 353(9):e2000036. PubMed ID: 32573008
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Design, synthesis, and biological evaluation of scutellarein carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer's disease.
    Sang ZP, Qiang XM, Li Y, Wu B, Zhang H, Zhao MG, Deng Y.
    Chem Biol Drug Des; 2015 Nov 01; 86(5):1168-77. PubMed ID: 25941042
    [Abstract] [Full Text] [Related]

  • 11. Synthesis, characterization and in vitro evaluation of substituted N-(2-phenylcyclopropyl)carbamates as acetyl- and butyrylcholinesterase inhibitors.
    Horáková E, Drabina P, Brož B, Štěpánková Š, Vorčáková K, Královec K, Havelek R, Sedlák M.
    J Enzyme Inhib Med Chem; 2016 Nov 01; 31(sup3):173-179. PubMed ID: 27476673
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Development of Piperazinediones as dual inhibitor for treatment of Alzheimer's disease.
    Kumar D, Gupta SK, Ganeshpurkar A, Gutti G, Krishnamurthy S, Modi G, Singh SK.
    Eur J Med Chem; 2018 Apr 25; 150():87-101. PubMed ID: 29524731
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. O-(triazolyl)methyl carbamates as a novel and potent class of fatty acid amide hydrolase (FAAH) inhibitors.
    Colombano G, Albani C, Ottonello G, Ribeiro A, Scarpelli R, Tarozzo G, Daglian J, Jung KM, Piomelli D, Bandiera T.
    ChemMedChem; 2015 Feb 25; 10(2):380-95. PubMed ID: 25338703
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.